Already pharma companies are changing their sales and earnings expectations because of legislative changes that take place immediately, such as increased Medicaid rebates. Johnson & Johnson today said changes to the U.S. system would pare 2010 earnings by about 10 cents a share and cut revenue by between $400 million and $500 million.
Apr20